Properties
|
N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine is an intermediate in the synthesis of afatinib, which is an aminocrotonylamino group Substituted quinazoline derivatives for the treatment of cancer and diseases of the respiratory tract and lungs, gastrointestinal tract, bile duct and gallbladder.
1000 Kilogram/Kilograms per Month
1G 10G 100G/BAG